Get the Stockscreener App
95.58
0.14%
0.13
After Hours:
95.73
0.15
+0.16%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $95.58, with a volume of 4.62M.
It is up +0.14% in the last 24 hours and up +1.65% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$95.45
Open:
$95.7
24h Volume:
4.62M
Relative Volume:
0.66
Market Cap:
$122.60B
Revenue:
$34.20B
Net Income/Loss:
$4.69B
P/E Ratio:
26.39
EPS:
3.6218
Net Cash Flow:
$5.30B
1W Performance:
-2.90%
1M Performance:
+1.65%
6M Performance:
+15.30%
1Y Performance:
+6.96%
1-Day Range:
$95.06
$96.41
1-Week Range:
$95.06
$99.37
52-Week Range:
$79.29
$99.37
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
Medtronic Stent Graft System Receives FDA Labeling Approval to Remove rAAA Treatment Warning - Diagnostic and Interventional Cardiology
Medtronic earns first-of-its-kind FDA labeling for Endurant stent graft - MassDevice
Medtronic Hugo robotic IDE trial targets gynaecology surgery precision and outcomes - Medical Device Network
Is Medtronic plc stock ready for a breakoutStock Surge & Free High Accuracy Swing Entry Alerts - newser.com
Verdence Capital Advisors LLC Has $2.56 Million Stock Position in Medtronic PLC $MDT - MarketBeat
Atria Wealth Solutions Inc. Decreases Stake in Medtronic PLC $MDT - MarketBeat
Yousif Capital Management LLC Lowers Stake in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Vest Financial LLC - MarketBeat
Medtronic PLC $MDT Shares Acquired by Pzena Investment Management LLC - MarketBeat
Leith Wheeler Investment Counsel Ltd. Has $30.13 Million Holdings in Medtronic PLC $MDT - MarketBeat
Stack Financial Management Inc Sells 2,987 Shares of Medtronic PLC $MDT - MarketBeat
Meritage Portfolio Management Sells 2,676 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Vanguard Personalized Indexing Management LLC - MarketBeat
Medtronic plc (MDT): Among Stocks to Buy from Dividend Stock Portfolio For Income - MSN
Medtronic plc stock trend forecastInsider Selling & Reliable Breakout Forecasts - newser.com
Brightwater Advisory LLC Acquires 2,673 Shares of Medtronic PLC $MDT - MarketBeat
Cerro Pacific Wealth Advisors LLC Buys 4,406 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Johnson Investment Counsel Inc. - MarketBeat
Medtronic PLC $MDT is Matrix Asset Advisors Inc. NY's 8th Largest Position - MarketBeat
Fifth Third Wealth Advisors LLC Has $1.98 Million Stock Holdings in Medtronic PLC $MDT - MarketBeat
Callan Family Office LLC Boosts Holdings in Medtronic PLC $MDT - MarketBeat
Precision Trading with Medtronic Plc. (MDT) Risk Zones - news.stocktradersdaily.com
What Is One of the Best Healthcare Stocks to Buy Right Now? (Hint: It's a Robotics Company) - The Motley Fool
JB Capital LLC Buys 6,515 Shares of Medtronic PLC $MDT - MarketBeat
Drucker Wealth 3.0 LLC Has $2.61 Million Holdings in Medtronic PLC $MDT - MarketBeat
Aberdeen Group plc Purchases 27,470 Shares of Medtronic PLC $MDT - MarketBeat
Venturi Wealth Management LLC Sells 4,008 Shares of Medtronic PLC $MDT - MarketBeat
Intuitive’s challengers continue to advance - MedTech Dive
RBC Raises Price Target on Medtronic to $111 From $103, Keeps Outperform Rating - MarketScreener
Medtronic (NYSE:MDT) Receives "Buy (B-)" Rating from Weiss Ratings - MarketBeat
US Bancorp DE Sells 97,898 Shares of Medtronic PLC $MDT - MarketBeat
Insight Inv LLC Cuts Stock Position in Medtronic PLC $MDT - MarketBeat
Columbus Macro LLC Purchases 13,416 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Sold by Leo Wealth LLC - MarketBeat
Medtronic PLC $MDT Holdings Decreased by Tectonic Advisors LLC - MarketBeat
Prime Capital Investment Advisors LLC Has $933,000 Stock Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic (NYSE:MDT) S&P Futures Trends in Medical Devices - Kalkine Media
Multi factor analysis applied to Medtronic plcTrade Volume Report & Reliable Intraday Trade Alerts - newser.com
How Medtronic Plc. (MDT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
What analysts say about Medtronic plc 2M6 stockBreakout Stock Watch & Low Entry Cost Investments - earlytimes.in
Stifel Maintains Medtronic (MDT) Hold Recommendation - Nasdaq
Medtronic (MDT) Falls More Steeply Than Broader Market: What Investors Need to Know - Nasdaq
Transcript : Medtronic plcSpecial Call - MarketScreener
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions - The Malaysian Reserve
Stifel Raises Medtronic (MDT) Price Target to $105, Maintains Ho - GuruFocus
Medtronic begins study of Hugo robot in gynecology - MedTech Dive
Medtronic Delivers on FY25 Sustainability Targets and Charts Path to 2030 - CSRwire
November 28th Options Now Available For Medtronic (MDT) - Nasdaq
Medtronic BrainSense Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions - Med-Tech Insights
Medtronic begins Embrace Gynecology study of Hugo RAS system - Medical Device Network
Stifel Adjusts Price Target on Medtronic to $105 From $90, Maintains Neutral Rating - MarketScreener
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.09%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):